← Back to Search

One-4-ALL Initiative for Literacy

N/A
Recruiting
Led By Jill Landsbaugh Kaar, PhD
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
All guardians of patients and the providers (surgeons, doctors, nurses, etc) that serve these patients.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-intervention (12 weeks)
Awards & highlights

Study Summary

This trial seeks to improve healthcare access and outcomes, reduce costs, and ensure provider well-being, especially for racial/cultural minorities and low-income families. #COVID19 #HealthcareAccess

Who is the study for?
The One-4-ALL Initiative is for all guardians of patients, including family members or friends responsible for their care, as well as healthcare providers like surgeons, doctors, and nurses serving these patients.Check my eligibility
What is being tested?
This trial tests the One-4-ALL Initiative against a control group to see if it can improve health outcomes, patient experiences, reduce healthcare costs and support healthcare provider well-being amidst challenges such as COVID-19.See study design
What are the potential side effects?
Since this study focuses on an initiative rather than a medical treatment or drug, there are no traditional side effects. However, participants may experience changes in workload or stress levels.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-intervention (12 weeks)
This trial's timeline: 3 weeks for screening, Varies for treatment, and post-intervention (12 weeks) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability of program tool
Health care quality
Patient satisfaction
+1 more

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: One-4-ALL InitiativeActive Control1 Intervention
The health app arm will pilot the intervention and key outcome measures will be compared between the Health App group and the placebo control.
Group II: ControlPlacebo Group1 Intervention
Will receive standard care.

Find a Location

Who is running the clinical trial?

University of Colorado, DenverLead Sponsor
1,738 Previous Clinical Trials
2,149,426 Total Patients Enrolled
Jill Landsbaugh Kaar, PhDPrincipal InvestigatorUniversity of Colorado - Anschutz Medical Campus

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the criterion for enrolling in this medical trial?

"This research project is seeking 100 individuals that fall within the 18 to 99 year old age range. Additionally, guardians and medical personnel required to look after these volunteers must also meet the eligibility requirements."

Answered by AI

Can individuals still apply to take part in this experiment?

"Affirmative. The clinicaltrials.gov website has information that indicates this medical trial, which initially opened up for recruitment on September 1st 2023, is still actively pursuing candidates. This study requires 100 individuals to be recruited from one site."

Answered by AI

Are persons aged over thirty able to partake in this medical experiment?

"This trial's eligibility requirements indicate that the age range for enrollment is 18 to 99."

Answered by AI

How many individuals are currently partaking in this scientific experiment?

"Affirmative, the information on clinicaltrials.gov affirms that this experiment is currently seeking volunteers. This trial was initially posted on September 1st 2023 and most recently revised December 4th of the same year. The research requires 100 participants to be recruited from a single centre."

Answered by AI
~30 spots leftby Jul 2024